Sign in

CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company

ATOSSA THERAPEUTICS, INC.

Sign in to watch
Ticker
ATOS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
264753208
Phone
206.588.0256
Business address
1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
Former names
ATOSSA GENETICS INC
  1. 10-Q Report Quarterly Report
  2. SC 13G Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. 8-K Event Material agreement · Other events
  7. 424B3 Offering Prospectus
  8. 424B3 Offering Prospectus
  9. 8-K Event Regulation FD disclosure · Other events
  10. EFFECT Other Notice of Effectiveness
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. UPLOAD Other SEC-generated Letter
  13. S-3 Offering Registration Statement
  14. 8-K Event Regulation FD disclosure · Other events
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 424B3 Offering Prospectus
  18. 8-K Event Shareholder rights changed
  19. 8-K Event Delisting notice
  20. 4 Derivatives Options or other derivatives

Page 18 of 33 · 643 filings